CRP and COVID-19: On univariable analysis, the baseline characteristics that predicted delayed treatment during the COVID-19 epidemic included lower CDAI scores (OR = 0.0991, 95% CI = 0.982–1.000, p = 0.05) and lower CRP levels (OR = 0.965, 95% CI = 0.933–0.998, p = 0.038), as presented in Table 2.